ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Iksuda Therapeutics raises $47m to progress ADC pipeline pharmatimes
June 08, 2021Newcastle, UK-headquartered Iksuda Therapeutics has announced the closing of a $47m (￡34m) financing round, with the funds to be used to support the advancement of its lead antibody drug conjugate (ADC) assets.
Pharma Sources Insight January 2025
